← Leaderboards
Alexander Huang
University Of Pennsylvania
$3,639,634
Attributed
$3,639,634
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,639,634 · 2
By mechanism
R01$2,633,070 · 1
K08$1,006,564 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Meenhard Herlyn$50,214,821
- Ravi K Amaravadi$13,477,656
- David J Goldhamer$9,824,473
- Robert H Vonderheide$28,425,019
- Ronen Marmorstein$40,497,435
Others in their field
Other Emerging Leaders on “T Cell Response”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- James Dale Berry · Brigham And Women'S Hospital$20,824,388
- Leslie M Schoop · The University Corporation, Northridge$17,700,000
- Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai$16,493,829
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
T Cell ResponseResearch PersonnelImmune Checkpoint BlockadeResponsePositioning AttributeProgramsClinical EfficacyGenetic TranscriptionMelanomaMinorityNeoadjuvant TherapyPd-1 BlockadeAnti-Pd1 TherapyClinical TrialsCancer PatientAntigensCollectionExhaustBiometryImpairmentCd8-Positive T-LymphocytesBloodCellsT-Lymphocyte
Grant awards (9)
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy$1,014,151
R01 · FY2025 · CA · contact PI
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy$536,024
R01 · FY2024 · CA · contact PI
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy$550,500
R01 · FY2023 · CA · contact PI
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade$91,084
K08 · FY2023 · CA · contact PI
Role of progenitor exhausted CD8 T cells and the progenitor niche in anti-PD1 efficacy$532,395
R01 · FY2022 · CA · contact PI
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade$228,870
K08 · FY2022 · CA · contact PI
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade$228,870
K08 · FY2021 · CA · contact PI
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade$228,870
K08 · FY2020 · CA · contact PI
Role of tumor burden in limiting durable reinvigoration by PD-1 blockade$228,870
K08 · FY2019 · CA · contact PI